Videos

GW Pharmaceuticals CEO: Cannabis As A Cure | Mad Money | CNBC

GW Pharmaceuticals CEO: Cannabis As A Cure | Mad Money | CNBC

Jim Cramer speaks with the CEO of a stock that is absolutely blazing on the street, and is up 90 percent this year

07.23.15
Related Searches:
Suggested For You
The Challenges in Developing Therapeutic Cannabis The Challenges in Developing Therapeutic Cannabis
GW Pharmaceuticals Appoints CFO, Adds UK Director GW Pharmaceuticals Appoints CFO, Adds UK Director
Biotica to Build Drug Dev. and Mnfg. Facility Biotica to Build Drug Dev. and Mnfg. Facility
DCAT Launches Networking Event in Barcelona to Serve Expanding Global Membership DCAT Launches Networking Event in Barcelona to Serve Expanding Global Membership
The Changing Biopharma Risk Landscape The Changing Biopharma Risk Landscape
Recipharm Expands Blow Fill Seal Capacity in Kaysersberg, France Recipharm Expands Blow Fill Seal Capacity in Kaysersberg, France
The Changing Biopharma Risk Landscape The Changing Biopharma Risk Landscape
The Evolving Landscape of Drug Development in China The Evolving Landscape of Drug Development in China
Where is The Silver Bullet for Alzheimer’s? Where is The Silver Bullet for Alzheimer’s?
Faster time to market: Speeding formulation with new wearable high volume injectors Faster time to market: Speeding formulation with new wearable high volume injectors
Inovio Pharmaceuticals CEO: Navy Seal Of Cancer Fighting | Mad Money | CNBC Inovio Pharmaceuticals CEO: Navy Seal Of Cancer Fighting | Mad Money | CNBC
GW Pharma Receives FDA Fast Track and EMA Orphan Designations GW Pharma Receives FDA Fast Track and EMA Orphan Designations
What is the Fair Price of a Cure? What is the Fair Price of a Cure?
GW Pharma Names Clinical Science VP GW Pharma Names Clinical Science VP
GW Gains Orphan Status for Epilepsy Treatment GW Gains Orphan Status for Epilepsy Treatment

Related Features

    Loading, Please Wait..